UiPath Launches Agentic Solutions to Strengthen Fraud Prevention and Accelerate Lending

New solutions automate financial crime investigations and loan origination and compliance workflows, dramatically improving operational efficiency and ensuring a seamless borrowing experience

UiPath (NYSE: PATH) , a global leader in agentic automation, today announced new purpose-built agentic AI solutions designed to help financial institutions automate complex operational workflows across financial crime, compliance, and loan origination while maintaining the security, transparency, and auditability required for regulatory compliance.

Financial institutions face mounting pressure from evolving regulatory requirements, heightened fraud risk, and growing expectations for faster, more seamless lending experiences—these challenges are often compounded by operational and data bottlenecks that slow investigations, delay loan decisions, and increase compliance risk. To address these issues, UiPath developed new purpose-built agentic AI solutions complemented by the recent acquisition of WorkFusion, a pioneer in AI agents for financial crime compliance, further strengthening UiPath's portfolio of agentic AI-powered solutions for the financial services industry.

"Banks and financial institutions are balancing two critical pressures, stricter regulatory expectations and growing demand for faster customer decisions," said Mark Rubinstein, Director of Product Management, Financial Services Solutions at UiPath. "UiPath Solutions address both by automating and orchestrating workflows across fraud detection, compliance, and lending — equipping teams to focus on high-value exceptions rather than full end-to-end reviews and accelerating transformation with minimal disruption. By integrating with and enhancing existing systems, banks can modernize at their own pace while minimizing disruption. This allows lending and compliance teams to move faster without compromising governance, providing them with full visibility and control while delivering a more efficient review experience."

Financial Services: Financial Crime Compliance

Incorporating WorkFusion's purpose-built AI agents for financial crime compliance into the UiPath Platform, the UiPath Solution for Financial Crime Compliance automates key analyst workflows including sanctions screening, alert review and adverse media monitoring—helping financial institutions reduce alert backlogs, improve investigator productivity, and strengthen regulatory compliance while maintaining robust governance and auditability.

AI agents analyze watchlist alerts, review contextual information across internal and external data sources, and identify and elevate relevant cases to investigators. Additionally, the adverse media agent continuously scans multiple news and information sources to detect and surface negative news mentions, dramatically reducing manual research time to provide early warning for fraudulent, risky client relationships while improving review consistency and expanding risk coverage.

"Since implementing an AI agent for Transaction Screening Alert Review, we've automated 61% of sanction-hit reviews and are handling an average of 14,000 alerts monthly, freeing up branch and operations resources, enabling faster payments, and improving the employee experience," said Onni Chan, Sanctions Compliance Manager, Valley National Bank. "This has been a significant win for us, driving a meaningful reduction in our OFAC volumes while helping us innovate and scale."

Banking: Loan Origination

For banking institutions, loan origination still has many manual and time-consuming steps, with many lenders relying on manual data entry, paper-based documents, and human review during underwriting.

The UiPath Solution for Loan Origination works seamlessly with existing loan origination systems, core banking platforms, and data sources to streamline the manual loan setup and QA/QC sub-processes. This enables lending teams to make informed decisions quickly and easily, with strong quality assurance and compliance to mitigate risk and ensure regulatory adherence.

The solution leverages UiPath Maestro â„¢ to orchestrate AI agents, automation workflows, and human decision making across existing lending platforms to automate loan review and validation, perform risk analysis, and manage auditing and escalations. By integrating seamlessly with existing systems, banks can accelerate loan processing times, reduce operational risk, and improve borrower experiences.

"At LMCU, we are continually seeking new ways to enhance efficiency and deliver exceptional service to our members," said Julie Oziemkiewicz, Director of Home Equity at LMCU. "Partnering with UiPath has allowed us to uncover valuable opportunities for automation within our Home Equity process. We're grateful to partner with UiPath and value their strong reputation, and we are excited about how their automation solutions can deliver benefits our members at LMCU."

"UiPath has partnered with Suncoast to streamline the review and audit process by collaborating on a platform designed to ingest loan documents, compare them to the system of record, and provide the team with quick insights," said Dottie Dunn, Intelligent Automation Director at Suncoast Credit Union. "This approach aims to speed up the review process and increase the team's capacity."

Learn more about the UiPath Solution for Financial Crime Compliance here and UiPath Solution for Loan Origination here and register for the UiPath Agentic AI Summit here . The event will be broadcast on March 25 in three time zones: 10:00 am GMT, 11:00 am EDT, and 3:00 pm AEDT.

About UiPath

UiPath (NYSE: PATH) is a global leader in agentic automation, empowering enterprises to harness the full potential of AI agents to autonomously execute and optimize complex business processes. The UiPath Platformâ„¢ uniquely combines controlled agency, developer flexibility, and seamless integration to help organizations scale agentic automation safely and confidently. Committed to security, governance, and interoperability, UiPath supports enterprises as they transition into a future where automation delivers on the full potential of AI to transform industries. For more information, visit www.uipath.com.

Media Contact
UiPath
pr@UiPath.com

Investor Relations Contact
UiPath
investor.relations@UiPath.com

News Provided by Business Wire via QuoteMedia

PATH
The Conversation (0)
Syntholene Publishes Independent Validation of Step-Change Cost Reduction for Synthetic Jet Fuel

Syntholene Publishes Independent Validation of Step-Change Cost Reduction for Synthetic Jet Fuel

Fuel Expert Robert Rapier Validates Syntholene's Unique Pathway to Low-Cost Hydrogen and Synthetic Aviation FuelSyntholene Energy Corp. (TSXV: ESAF) (FSE: 3DD0) (OTCQB: SYNTF) ("Syntholene" or the "Company") has published an independent technical and economic report (the "Report") that validates... Keep Reading...
Zanaga Iron (AIM:ZIOC)

Robust Project Economics Confirmed Following Completion of DRI Process Plant Costing

Update on Strategic Investment in Zanaga Project

Zanaga Iron Ore Company Limited (AIM: ZIOC) is pleased to announce the successful completion of the project development strategy programme (the "Programme"), which now includes the results of a technical and commercial evaluation of the process flowsheet to produce premium quality Direct Reduced... Keep Reading...
A Fully Funded Junior in the Middle of a Q2 Catalyst Window: NevGold Heads Into Maiden Antimony-Gold MRE With C$42.2M in the Treasury

A Fully Funded Junior in the Middle of a Q2 Catalyst Window: NevGold Heads Into Maiden Antimony-Gold MRE With C$42.2M in the Treasury

Baystreet.ca News Commentary Issued on behalf of Nevgold Corp.Nevgold Corp. (TSX-V: NAU | OTCQX: NAUFF | FRA: 5E50) closes one of the most catalyst-dense six-week stretches in its corporate history — upsized brokered financing, 1.11% antimony drill hits, up to 99% gold recovery metallurgy, and a... Keep Reading...
BriaCell Receives FDA Clearance to Initiate Bria-BRES+ Clinical Study in Breast Cancer

BriaCell Receives FDA Clearance to Initiate Bria-BRES+ Clinical Study in Breast Cancer

FDA clearance of Investigational New Drug (IND) application opens path to commence Phase 1/2a clinical study for Bria-BRES+ in metastatic breast cancerBria-BRES+ is BriaCell's next generation personalized immunotherapy for breast cancer, and features additional immune activating components... Keep Reading...
Brixton Metals Announces Start of Drilling at its Atlin Goldfields Project

Brixton Metals Announces Start of Drilling at its Atlin Goldfields Project

Brixton Metals Corporation (TSX-V: BBB, OTCQX: BBBXF) (the "Company" or "Brixton") announces that drilling has begun at its Atlin Goldfields Project, located in Northwest British Columbia. Eldorado Gold Corporation ("Eldorado") has a path to one hundred percent ownership as per the Earn-in... Keep Reading...

Interactive Chart

Latest Press Releases

Related News